MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Motor Fluctuations development is associated with non-motor symptoms burden progression in Parkinson´s disease patients. A 2-year follow-up study.

D. Santos, T. de Deus, C. Cores, M. Feal Painceiras, E. Suárez Castro, C. Martínez, S. Jesús, M. Aguilar, P. Pastor, L. Planellas, M. Cosgaya, J. García Caldentey, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. Avila, V. Gómez Mayordomo, V. Nogueira, V. Puente, J. Dotor, C. Borrué, B. Solano, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo, J. Martínez Castrillo, P. Sánchez Alonso, M. Alonso Losada, N. López Ariztegui, I. Gastón, J. Kulisevsky, M. Blázquez, M. Seijo, J. Ruíz Martínez, C. Valero, M. Kurtis, O. de Fábregues, J. González, R. Alonso Redondo, C. Ordás, L. López Díaz, D. Mcafee, P. Martínez Martín, P. Mir, C. Coppadis (A Coruña, Spain)

Meeting: 2022 International Congress

Abstract Number: 1493

Keywords: Development, Motor control, Parkinson’s

Category: Parkinson's Disease: Non-Motor Symptoms

Objective: The aim of the present study was to analyze the progression of non-motor symptoms (NMS) burden in Parkinson´s disease (PD) patients regarding the development of motor fluctuations (MF). Moreover, the change in health-related quality of life (HR-QoL) was analyzed as well.

Background: Recently, we observed in a cross-sectional study that NMS burden is strongly correlated to motor complications in patients with PD [1].

Method: PD patients without MF at baseline, who were recruited from January/2016 to November/2017 (baseline visit; V0) and evaluated again at 2-year follow-up (V2; 24 months ± 1 month) from 35 centers of Spain from the COPPADIS cohort [2], were included in this analysis. MF development at V2 was defined as a score ≥ 1 in the item-39 of the Unified Parkinson´s Disease Rating Scale – Part IV (UPDRS-IV-item/39) whereas NMS burden according to the Non-Motor Symptoms Scale (NMSS) total score. The HR-QoL was assessed with the 39-item Parkinson’s disease Questionnaire (PDQ-39).

Results: Three hundred and thirty PD patients (62.6 ± 8.7 years old; 58.8% males) were included. From V0 to V2, 27.6% of the patients developed MF. The mean NMSS total score at baseline was higher in those patients who developed MF after the 2-year follow-up (46.3 ± 36.4 vs 34.3 ± 29.1; p=0.001) (Figure 1). A greater increase in the NMSS total score from V0 to V2 was observed in those patients who developed MF (+ 16.0 ± 37.3) compared to those who didn´t develop MF (+ 6.2 ± 25.8) (p=0.021). Similar results were observed in terms of HR-QoL (Figure 2). To develop MF after a 2-year follow-up was associated with an increase in the NMSS total score (β=0.137; p=0.025) after adjustment to age, gender, levodopa equivalent daily dose, years from symptoms onset and the NMSS total score at baseline.

Conclusion: In PD patients, the development of MF is associated with a greater increase in the NMS burden and HR-QoL impairment after a 2-year follow-up.

Figure.1

Figure.2

References: 1. Santos-García D, de Deus Fonticoba T, Suárez Castro E, et al.; COPPADIS Study Group, McAfee D. Non-motor symptom burden is strongly correlated to motor complications in patients with Parkinson’s disease. Eur J Neurol 2020;27:1210-23.
2. Santos-García D, Mir P, Cubo E, et al.; COPPADIS Study Group. COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015), a global–clinical evaluations, serum biomarkers, genetic studies and neuroimaging–prospective, multicenter, non-interventional, long-term study on Parkinson’s disease progression. BMC Neurol 2016;16:26.

To cite this abstract in AMA style:

D. Santos, T. de Deus, C. Cores, M. Feal Painceiras, E. Suárez Castro, C. Martínez, S. Jesús, M. Aguilar, P. Pastor, L. Planellas, M. Cosgaya, J. García Caldentey, N. Caballol, I. Legarda, J. Hernández Vara, I. Cabo, L. López Manzanares, I. González Aramburu, M. Avila, V. Gómez Mayordomo, V. Nogueira, V. Puente, J. Dotor, C. Borrué, B. Solano, M. álvarez Sauco, L. Vela, S. Escalante, E. Cubo, F. Carrillo, J. Martínez Castrillo, P. Sánchez Alonso, M. Alonso Losada, N. López Ariztegui, I. Gastón, J. Kulisevsky, M. Blázquez, M. Seijo, J. Ruíz Martínez, C. Valero, M. Kurtis, O. de Fábregues, J. González, R. Alonso Redondo, C. Ordás, L. López Díaz, D. Mcafee, P. Martínez Martín, P. Mir, C. Coppadis. Motor Fluctuations development is associated with non-motor symptoms burden progression in Parkinson´s disease patients. A 2-year follow-up study. [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/motor-fluctuations-development-is-associated-with-non-motor-symptoms-burden-progression-in-parkinsons-disease-patients-a-2-year-follow-up-study/. Accessed July 11, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/motor-fluctuations-development-is-associated-with-non-motor-symptoms-burden-progression-in-parkinsons-disease-patients-a-2-year-follow-up-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley